Coffee and cancer risk: A summary overview

European Journal of Cancer Prevention

Volumn 26, Issue 5, 2017, Pages 424-432

  Alicandro, Gianfranco ^a   Tavani, Alessandra ^b   La Vecchia, Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

cancer; coffee; incidence; mortality; review; risk

Indexed keywords

LIVER ENZYME; ANTIOXIDANT;

BILIARY TRACT CANCER; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER LOCALIZATION; CANCER RISK; CHILDHOOD LEUKEMIA; COFFEE; COLORECTAL CANCER; CONFIDENCE INTERVAL; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; GALLBLADDER CANCER; HUMAN; KIDNEY CANCER; LIVER CANCER; LIVER CIRRHOSIS; LUNG CANCER; OROPHARYNX CANCER; OVARY CANCER; PANCREAS CANCER; PREGNANCY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; SKIN CANCER; SMALL INTESTINE CANCER; SMOKING; SOFT TISSUE SARCOMA; STOMACH CANCER; THYROID CANCER; CHEMICALLY INDUCED; CHEMISTRY; COLORECTAL TUMOR; LIVER TUMOR; META ANALYSIS; NEOPLASM; PHYSIOLOGY;

ANTIOXIDANTS; COFFEE; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; NEOPLASMS; RISK FACTORS;

EID: 85014997284     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000341     Document Type: Review

References (73)

1. Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B, et al. (2011). Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol 85: 863-871.
2. Bhoo-Pathy N, Uiterwaal C, Dik V, Jeurnink S, Bech B, Overvad K, et al. (2013). Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study. Clin Gastroenterol Hepatol 11: 1486-1492.
3. Bidel S, Hu G, Jousilahti P, Antikainen R, Pukkala E, Hakulinen T, et al. (2010). Coffee consumption and risk of colorectal cancer. Eur J Clin Nutr 64: 917-923.
4. Boekema P, Samsom M, van Berge Henegouwen G, Smout A. (1999). Coffee and gastrointestinal function: facts and fiction: a review. Scand J Gastroenterol 34: 35-39.
5. Borrelli R, Visconti A, Mennella C, Anese M, Fogliano V. (2002). Chemical characterization and antioxidant properties of coffee melanoidins. J Agric Food Chem 50: 6527-6533.
6. Bosetti C, Turati F, La Vecchia C. (2014). Hepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol 28: 753-770.
7. Braem MGM, Onland-Moret NC, Schouten LJ, Tjønneland A, Hansen L, Dahm CC, et al. (2012). Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-Analysis. Am J Clin Nutr 95: 1172-1181.
8. Bravi F, Scotti L, Bosetti C, Gallus S, Negri E, La Vecchia C, et al. (2009). Coffee drinking and endometrial cancer risk: a meta-Analysis of observational studies. Am J Obs Gynecol 200: 130-135.
9. Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. (2013). Coffee reduces risk for hepatocellular carcinoma: an updated meta-Analysis. Clin Gastroenterol Hepatol 11: 1413-1421.
10. Bravi F, Tavani A, Bosetti C, Boffetta P, La Vecchia C. (2016). Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-Analysis of prospective studies. Eur J Cancer Prev [Epub ahead of print].
11. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. (2002). Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40: 1155-1163.
12. Cheng J, Su H, Zhu R, Wang X, Peng M, Song J, et al. (2014). Maternal coffee consumption during pregnancy and risk of childhood acute leukemia: a metaanalysis. Am J Obstet Gynecol 210: 151.e1-151.e10.
13. Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. (2014). Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-Analysis. Am J Epidemiol 180: 763-775.
14. De Pergola G, Silvestris F. (2013). Obesity as a major risk factor for cancer. J Obes 2013: 291546.
15. Dik VK, Bueno-de-Mesquita HB, Van Oijen MG, Siersema PD, Uiterwaal CS, Van Gils CH, et al. (2014). Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study. Int J Cancer 135: 401-412.
16. Discacciati A, Orsini N, Wolk A. (2014). Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer - A dose-response metaanalysis. Ann Oncol 25: 584-591.
17. Freedman N, Curto T, Lindsay K, Wright E, Sinha R, Everhart E. (2011). Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C. Gatroenterology 140: 1961-1969.
18. Galarraga V, Boffetta P. (2016). Coffee drinking and risk of lung cancer - A metaanalysis. Cancer Epidemiol Biomarkers Prev 25: 951-957.
19. Galeone C, Tavani A, Pelucchi C, Turati F, Winn DM, Levi F, et al. (2010a). Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol biomarkers Prev., 19: 1723-1736.
20. Galeone C, Turati F, La Vecchia C, Tavani A. (2010). Coffee consumption and risk of colorectal cancer: a meta-Analysis of case-control studies. Cancer Causes Control 21: 1949-1959.
21. Guertin K, Freedman N, Loftfield E, Stolzenberg-Solomon R, Graubard B, Sinha R. (2015). A prospective study of coffee intake and pancreatic cancer: results from the NIH-AARP Diet and Health Study. Br J Cancer 113: 1081-1085.
22. Hashibe M, Galeone C, Buys SS, Gren L, Boffetta P, Zhang Z. (2015). Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. Br J Cancer 113: 809-816.
23. Huang T, Guo Z, Zhang X, Zhang X, Liu H, Geng J, et al. (2014). Coffee consumption and urologic cancer risk: a meta-Analysis of cohort studies. Int urol Nephrol 46: 1481-1493.
24. Huber WW, Rossmanith W, Grusch M, Haslinger E, Prustomersky S, Peter-Vörösmarty B, et al. (2008). Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem Toxicol 46: 1230-1238.
25. IARC. (1991). Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 27 February to 6 March 1990. IARC Monogr Eval Carcinog Risks Hum 51: 1-513.
26. Je Y, Giovannucci E. (2012). Coffee consumption and risk of endometrial cancer: findings from a large up-To-date meta-Analysis. Int J Cancer 131: 1700-1710.
27. Jiang W, Wu Y, Jiang X. (2013). Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-Analysis of 37 published studies. Gynecol Oncol 129: 620-629.
28. Johnston KL, Clifford MN, Morgan LM. (2003). Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 78: 728-733.
29. Jokura H, Watanabe I, Umeda M, Hase T, Shimotoyodome A. (2015). Coffee polyphenol consumption improves postprandial hyperglycemia associated with impaired vascular endothelial function in healthy male adults. Nutr Res 35: 873-881.
30. Kleeff J, Korc M, Apte M, Vecchia C, La, Johnson CD, Biankin AV, et al. (2016). Pancreatic cancer. Nat Rev Dis Primers 2: 16022.
31. La Vecchia C, Tavani A. (2007). Coffee and cancer risk: an update. Eur J Cancer Prev 16: 385-389.
32. La Vecchia C, Franceschi S, Decarli A, Gentile A, Liati P, Regallo M, et al. (1984). Coffee drinking and the risk of epithelial ovarian cancer. Int J Cancer 33: 559-562.
33. La Vecchia C, Negri E, Franceschi S, Parazzini F, Decarli A. (1992). Differences in dietary intake with smoking, alcohol, and education. Nutr Cancer 17: 297-304.
34. La Vecchia C, Negri E, Decarli A, Franceschi S. (1997). Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 73: 204-207.
35. Lees B, Leath C. (2015). The impact of diabetes on gynecologic cancer: current status and future directions. Curr Obs Gynecol Rep 4: 234-239.
36. Li L, Gan Y, Wu C, Qu X, Sun G, Lu Z. (2015). Coffee consumption and the risk of gastric cancer: a meta-Analysis of prospective cohort studies. BMC Cancer 15: 733.
37. Li Y, Peng J, Li L. (2016). Coffee consumption associated with reduced risk of oral cancer : a meta-Analysis. Oral Surgery, Oral Med Oral Pathol Oral Radiol 121: 381.e1-389.e1.
38. Liu F, Wang X, Wu G, Chen L, Hu P, Ren H, et al. (2015). Coffee consumption decreases risks for hepatic fibrosis and cirrhosis: a meta-Analysis. PLoS One 10: e0142457.
39. Lukic M, Licaj I, Lund E, Skeie G, Weiderpass E, Braaten T. (2016). Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study. Eur J Epidemiol 31: 905-916.
40. Mack W, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, et al. (2003). A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control 14: 773-785.
41. MacMahon B, Yen S, Trichopoulos D, Warren K, Nardi G. (1981). Coffee and cancer of the pancreas. N Engl J Med 12: 630-633.
42. Malerba S, Turati F, Galeone C, Tavani A. (2013). A meta-Analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol 28: 527-539.
43. Malerba S, Galeone C, Pelucchi C, Turati F, Hashibe M, La Vecchia C, et al. (2013b). A meta-Analysis of coffee and tea consumption and the risk of glioma in adults. Cancer Causes Control 24: 267-276.
44. Michikawa T, Inoue M, Shimazu T, Sasazuki S, Iwasaki M, Sawada N, et al. (2011). Green tea and coffee consumption and its association with thyroid cancer risk: a population-based cohort study in Japan. Cancer Causes Control 22: 985-993.
45. Mills C, Tzounis X, Oruna-Concha M, Mottram D, Gibson G, Spencer J. (2015). In vitro colonic metabolism of coffee and chlorogenic acid results in selective changes in human faecal microbiota growth. Br J Nutr 113: 1220-1227.
46. Milne E, Royle JA, Bennett LC, De Klerk NH, Bailey HD, Bower C, et al. (2011). Maternal consumption of coffee and tea during pregnancy and risk of childhood ALL: results from an Australian case-control study. Cancer Causes Control 22: 207-218.
47. Modi A, Feld J, Park Y, Kleiner D, Everhart J, Liang T, et al. (2010). Increased caffeine consumption is associated with reduces hepatic fibrosis. Hepatology 51: 201-209.
48. Nakamura T, Ishikawa H, Mutoh M, Wakabayashi K, Kawano A, Sakai T, et al. (2016). Coffee prevents proximal colorectal adenomas in Japanese men: a prospective cohort study. Eur J Cancer Prev 25: 388-394.
49. Naldi L, Gallus S, Tavani A, Imberti G, La Vecchia C. (2004). Risk of melanoma and vitamin A, coffee and alcohol: a case-control study from Italy. Eur J Cancer Prev 13: 503-508.
50. Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B. (2010). Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 21: 1533-1544.
51. Orsi L, Rudant J, Ajrouche R, Leverger G, Baruchel A, Nelken B, et al. (2015). Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy, and childhood acute leukemia: the ESTELLE study. Cancer Causes Control 26: 1003-1017.
52. Pulido R, Hernandez-Garcia M, Saura Calixto F. (2003). Contribution of beverages to the intake of lipophilic and hydrophilic antioxidants in the Spanish diet. Eur J Clin Nutr 57: 1275-1282.
53. Rosato V, Zucchetto A, Bosetti C, Dal Maso L, Montella M, Pelucchi C, et al. (2011). Metabolic syndrome and endometrial cancer risk. Ann Oncol 22: 884-889.
54. Ruhl CE, Everhart JE. (2005). Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 128: 24-32.
55. Saab S, Mallam D, Cox GA, Tong MJ. (2014). Impact of coffee on liver diseases: a systematic review. Liver Int 34: 495-504.
56. Schmit SL, Rennert HS, Rennert G, Gruber SB. (2016). Coffee consumption and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 25: 634-639.
57. Seril DN, Liao J, Yang GY, Y CS. (2003). Oxidative stress and ulcerative colitisassociated carcinogenesis: studies in humans and animal models. Carcinogenesis 24: 353-362.
58. Shearer J, Farah A, de Paulis T, Bracy DP, Pencek RR, Graham TE, et al. (2003). Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr 133: 3529-3532.
59. Shi H, Shi A, Dong L, Lu X, Wang Y, Zhao J, et al. (2016). Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress. Clin Nutr 35: 1366-1373.
60. Shin C, Strayer J, Wani M, Snapka R. (1990). Rapid evaluation of topoisomerase inhibitors: caffeine inhibition of topoisomerases in vivo. Teratog Carcinog Mutagen 10: 41-52.
61. Sinha R, Cross AJ, Daniel CR, Graubard BI, Wu JW, Hollenbeck AR, et al. (2012). Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 96: 374-381.
62. Steevens J, Schouten LJ, Verhage BAJ, Goldbohm RA, van den Brandt PA. (2007). Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-Analysis. Br J Cancer 97: 1291-1294.
63. Thomopoulos TP, Ntouvelis E, Diamantaras AA, Tzanoudaki M, Baka M, Hatzipantelis E, et al. (2015). Maternal and childhood consumption of coffee, tea and cola beverages in association with childhood leukemia: a metaanalysis. Cancer Epidemiol 39: 1047-1059.
64. Turati F, Galeone C, Vecchia C, La, Garavello W, Tavani A. (2011). Coffee and cancers of the upper digestive and respiratory tracts: meta-Analyses of observational studies. Ann Oncol 22: 536-544.
65. Turati F, Galeone C, Edefonti V, Ferraroni M, Lagiou P, La Vecchia C, et al. (2012). A meta-Analysis of coffee consumption and pancreatic cancer. Ann Oncol 23: 311-318.
66. Turati F, Bosetti C, Polesel J, Zucchetto A, Serraino D, Montella M, et al. (2015). Coffee, tea, cola, and bladder cancer risk: dose and time relationships. Urology 86: 1179-1184.
67. van Dam R, Hu F. (2012). Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294: 97-104.
68. Vitaglione P, Fogliano V, Pellegrini N. (2012). Coffee, colon function and colorectal cancer. Food Funct 3: 916-922.
69. Wu W, Tong Y, Zhao Q, Yu G, Wei X, Lu Q. (2015). Coffee consumption and bladder cancer: a meta-Analysis of observational studies. Sci Rep 5: 9051.
70. Yamada H, Kawado M, Aoyama N, Hashimoto S, Suzuki K, Wakai K, et al. (2014). Coffee consumption and risk of colorectal cancer: the Japan Collaborative Cohort Study. J Epidemiol 24: 370-378.
71. Zamora-Ros R, Luján-Barroso L, Bueno-de-Mesquita HB, Dik VK, Boeing H, Steffen A, et al. (2014). Tea and coffee consumption and risk of esophageal cancer: the European prospective investigation into cancer and nutrition study. Int J Cancer 135: 1470-1479.
72. Zhang X, Albanes D, Beeson WL, Van Den Brandt PA, Buring JE, Flood A, et al. (2010). Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst 102: 771-783.
73. Zhou Q, Luo M, Li H, Li M, Zhou J. (2015). Coffee consumption and risk of endometrial cancer: a dose-response meta-Analysis of prospective cohort studies. Sci Rep 5: 13410.